Squarepoint’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-33,058
Closed -$406K 4002
2022
Q4
$406K Buy
+33,058
New +$788K ﹤0.01% 2404

Squarepoint's CINC Position: Q1 2023 in Review

Squarepoint sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 33,058 shares — an estimated $406K sold.

Squarepoint first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $406K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • Squarepoint reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Squarepoint sold 33,058 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $406K.
  • Squarepoint first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Squarepoint's CinCor Pharma, Inc. Common Stock position peaked at $406K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Squarepoint's 13F filing for Q1 2023, filed 15 May 2023.